These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11857305)

  • 41. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction.
    Murono S; Yoshizaki T; Tanaka S; Takeshita H; Park CS; Furukawa M
    Laryngoscope; 1997 Apr; 107(4):523-6. PubMed ID: 9111384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].
    Luo YL; Chen H; Peng SG; Lin JH; Huang PY
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3516-9. PubMed ID: 24521892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Assay of Epstein-Barr virus in nasopharyngeal tissues and serum of patients with nasopharyngeal carcinoma].
    Li XM; Yang CZ; Chen PJ; Su ZL; Song Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Sep; 14(9):400-1. PubMed ID: 12563909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein-Barr virus DNA load.
    Xu T; Su B; Huang P; Wei W; Deng Y; Sehgal V; Wang D; Jiang J; Zhang G; Li A; Yang H; Claret FX
    Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 27883284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative plasma/serum EBV DNA load by LMP2A determination in an Italian cohort of NPC patients.
    Pratesi C; Bortolin MT; D'Andrea M; Vaccher E; Barzan L; Bidoli E; Tedeschi R; Zanussi S; de Paoli P
    J Clin Virol; 2003 Oct; 28(2):155-64. PubMed ID: 12957185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
    Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
    J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of plasma Epstein-Barr Virus DNA loads in a large cohort of Malaysian patients with nasopharyngeal carcinoma.
    Chai SJ; Pua KC; Saleh A; Yap YY; Lim PV; Subramaniam SK; Lum CL; Krishnan G; Mahiyuddin WR; ; Teo SH; Khoo AS; Yap LF
    J Clin Virol; 2012 Sep; 55(1):34-9. PubMed ID: 22739102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine.
    Sengar M; Chorghe S; Jadhav K; Singh S; Laskar SG; Pai P; Aggarwal JP; D'Cruz A; Chaturvedi P; Deshpande M; Chaukar D; Budrukkar A; Gupta T; Murthy V; Kane S; Thakur M; Rangarajan V; Kannan S; Shet T; Kode J
    Head Neck; 2016 Apr; 38 Suppl 1():E1666-73. PubMed ID: 26667883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of two laboratory extraction techniques for the detection of Epstein-Barr virus in the saliva of nasopharyngeal carcinoma patients.
    Shan J; Pow EH; Tsang PC; Perera RA; Kwong DL
    J Investig Clin Dent; 2014 May; 5(2):104-8. PubMed ID: 24574317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma.
    Tsang NM; Chuang CC; Tseng CK; Hao SP; Kuo TT; Lin CY; Pai PC
    Cancer; 2003 Dec; 98(11):2385-92. PubMed ID: 14635073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
    Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
    Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
    Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
    Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical applications of plasma Epstein-Barr virus DNA analysis and protocols for the quantitative analysis of the size of circulating Epstein-Barr virus DNA.
    Chan KC; Lo YM
    Methods Mol Biol; 2006; 336():111-21. PubMed ID: 16916257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nasopharyngeal swab and PCR for the screening of nasopharyngeal carcinoma in the endemic area: a good supplement to the serologic screening.
    Sheen TS; Ko JY; Chang YL; Chang YS; Huang YT; Chang Y; Tsai CH; Hsu MM
    Head Neck; 1998 Dec; 20(8):732-8. PubMed ID: 9790296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy.
    An X; Wang FH; Ding PR; Deng L; Jiang WQ; Zhang L; Shao JY; Li YH
    Cancer; 2011 Aug; 117(16):3750-7. PubMed ID: 21319149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR.
    Takeuchi H; Kobayashi R; Hasegawa M; Hirai K
    Arch Virol; 1997; 142(9):1743-56. PubMed ID: 9672634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymerase chain reaction study of Epstein-Barr virus in high risk group of nasopharyngeal carcinoma: a preliminary report.
    Luxamechanporn T; Neimhom S; Kunachak S; Kulapaditharom B
    J Med Assoc Thai; 1999 Jun; 82(6):593-7. PubMed ID: 10443082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
    Huang J; Fogg M; Wirth LJ; Daley H; Ritz J; Posner MR; Wang FC; Lorch JH
    Cancer; 2017 Jul; 123(14):2642-2650. PubMed ID: 28222215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.